Clinical Trial Update: Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating atezolizumab in combination with stereotactic ablative radiotherapy for metastatic colorectal cancer, non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Sarcoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma ) | Phase 2 | Status: ACTIVE_NOT_RECRUITING